Program overview
Context
Indication: Recurrent Chronic Lymphocytic Leukemia
Mechanism: Unknown
Modality: Unknown
Sponsor: M.D. Anderson Cancer Center
Registry Stop Signal
Lenalidomide
Lenalidomide is flagged as registry stop signal because public records show a registry stop signal, timeline staleness. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 3/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT02225275 | https://clinicaltrials.gov/study/NCT01412307
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02225275 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | None |
| NCT01412307 | Unknown Status Signal (UNKNOWN) | stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | Low Signal | None |